A systematic review of adverse events following immunization during pregnancy and the newborn period (Q28081836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

A systematic review of adverse events following immunization during pregnancy and the newborn period (English)

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Justin R Ortiz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

6

Saad B Omer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Divya Narayanan

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Philipp Lambach

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

T Roice Fulton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

1 reference

26 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

33

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

47

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

6453-6465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Influenza vaccination of pregnant women and protection of their infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Global and national initiatives to facilitate studies of vaccines in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of influenza immunization during pregnancy for the fetus and the neonate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Influenza vaccination and fetal and neonatal outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Reporting of vaccine safety data in publications: systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Background rates of adverse pregnancy outcomes for assessing the safety of maternal vaccine trials in sub-Saharan Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Pharmacovigilance monitoring of a cohort of pregnant women vaccinated against influenza A(H1N1) variant virus in the Nord-Pas de Calais region of northern France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Selective uptake of influenza vaccine and pregnancy outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Early exposure to yellow fever vaccine during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Inflammatory responses to trivalent influenza virus vaccine among pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of the pandemic H1N1 influenza vaccine among pregnant U.S. military women and their newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety profile of the yellow fever vaccine Stamaril®: a 17-year review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of post-exposure rabies prophylaxis during pregnancy: a follow-up study from Guangzhou, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Vaccination against H1N1 influenza with Pandemrix(®) during pregnancy and delivery outcome: a Swedish register study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

AdimFlu-S(®) influenza A (H1N1) vaccine during pregnancy: the Taiwanese Pharmacovigilance Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Influenza H1N1 vaccination and adverse pregnancy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of influenza vaccination during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Maternal safety of trivalent inactivated influenza vaccine in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Maternal influenza vaccine and risks for preterm or small for gestational age birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Vaccine prevention of maternal cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Rubella vaccination of unknowingly pregnant women: the São Paulo experience, 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Effect of influenza vaccination in the first trimester of pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Efficacy of an accelerated hepatitis B vaccination program during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Maternal outcomes among pregnant women receiving live attenuated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Postlicensure safety surveillance for varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.043

10.1016/J.VACCINE.2015.08.043

7 January 2021

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json

release_p7gbecno2fh5fjosgfcghmbzne

25 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p7gbecno2fh5fjosgfcghmbzne

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26413879%20AND%20SRC:MED&resulttype=core&format=json